{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T04:33:43Z","timestamp":1716957223372},"reference-count":21,"publisher":"Informa UK Limited","issue":"sup1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecological Endocrinology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1080\/09513590400030038","type":"journal-article","created":{"date-parts":[[2005,9,6]],"date-time":"2005-09-06T17:45:19Z","timestamp":1126028719000},"page":"1-5","source":"Crossref","is-referenced-by-count":10,"title":["The role of mammographic density in evaluating changes in breast cancer risk"],"prefix":"10.1080","volume":"21","author":[{"given":"Malcolm C","family":"Pike","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"CIT0001","first-page":"3243","volume":"289","author":"Chlebowski RT","year":"2003","journal-title":"et al., the Writing Group for the Women's Health Initiative Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"Anderson GL","year":"2004","journal-title":"JAMA"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6","volume":"81","author":"Magnusson C","year":"1999","journal-title":"Int J Cancer"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","volume":"92","author":"Ross RK","year":"2000","journal-title":"J Nat Cancer Inst"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.4.485"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0277-5379(88)90173-3","volume":"24","author":"Key TJ","year":"1988","journal-title":"Eur J Cancer"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0140-6736(92)93064-T","volume":"340","author":"Persson I","year":"1992","journal-title":"Lancet"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1148\/radiology.174.1.2152982","volume":"174","author":"Berkowitz JE","year":"1990","journal-title":"Radiology"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0039-128X(00)00122-7","volume":"65","author":"Pike MC","year":"2000","journal-title":"Steroids"},{"key":"CIT0010","first-page":"767","volume":"303","author":"Pike MC","year":"1983","journal-title":"'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(95)92713-1","volume":"346","author":"Hulka BS","year":"1995","journal-title":"Lancet"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.epirev.a036102","volume":"15","author":"Pike MC","year":"1993","journal-title":"Epidemiol Rev"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1981.168"},{"key":"CIT0014","first-page":"106","volume":"47","author":"Dickey RP","year":"1976","journal-title":"Obstet Gynecol"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0010-7824(81)90045-7","volume":"23","author":"Back DJ","year":"1981","journal-title":"Contraception"},{"key":"CIT0016","first-page":"4559","volume":"84","author":"Hofseth LJ","year":"1999","journal-title":"Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopau-sal breast. J Clin Endocrinol Metab"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14065-2"},{"key":"CIT0019","first-page":"670","volume":"87","author":"Boyd NF","year":"1995","journal-title":"Yaffe MJ. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Nat Cancer Inst"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/95.1.30","volume":"95","author":"Greendale GA","year":"2003","journal-title":"J Nat Cancer Inst"},{"key":"CIT0021","first-page":"2842","volume":"22","author":"Ursin G","year":"2004","journal-title":"Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in Postmenopausal Estrogen\/Progstin Interventions (PEPI) Trial. J Chin Oncol"},{"key":"CIT0022","first-page":"431","volume":"86","author":"Spicer DV","year":"1994","journal-title":"Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Nat Cancer Inst"}],"container-title":["Gynecological Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09513590400030038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T23:07:53Z","timestamp":1497654473000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09513590400030038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":21,"journal-issue":{"issue":"sup1","published-online":{"date-parts":[[2009,7,7]]},"published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1080\/09513590400030038"],"URL":"https:\/\/doi.org\/10.1080\/09513590400030038","relation":{},"ISSN":["0951-3590","1473-0766"],"issn-type":[{"value":"0951-3590","type":"print"},{"value":"1473-0766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}